期刊名称：PSYCHOPHARMACOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Psychopharmacology
"Psychopharmacology" is an international journal that covers the general area of elucidating mechanisms by which drugs affect behavior. The scope of the journal extends from clinical psychopharmacology (including trials), to experimental studies on the effects of drugs on cognition and behavior in humans and laboratory studies in experimental animals. The research methodologies (techniques covered) may range from neurochemical assays and electrophysiological recording to studies of functional neuroimaging, and the methods of experimental psychology and ethology, as well as clinical neurology and psychiatry. The journal is particularly interested in articles that integrate these levels of analysis.
Instructions to Authors
Manuscript submission
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities ?tacitly or explicitly ?at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Authors should submit their manuscripts online. Electronic submission substantially reduces the editorial processing and reviewing times and shortens overall publication times. Please follow the hyperlink 揝ubmit online?on the right and upload all of your manuscript files following the instructions given on the screen.
More Details please see the PDF file below.
Instructions to Authors
0033-3158.pdf
Editorial Board
Editorial Board
Clinical psychopharmacology
For North and South America
Principal editor
L.H. Price, Providence
Advisory editors
W.F. Gattaz, São Paulo
J. Kennedy, Toronto
C.J. McDougle, Indianapolis
For the rest of the world
Principal editor
P.J. Cowen, Oxford
Advisory editors
K. Ebmeier, Edinburgh
D. Naber, Hamburg
D.J. Nutt, Bristol
Human experimental psychopharmacology
For North and South America
Principal editor
H. de Wit, Chicago
Advisory editors
G. Bigelow, Baltimore
M. Haney, New York
S.S. O'Malley, New Haven
K.A. Perkins, Pittsburgh
T. Roehrs, Detroit
For the rest of the world
Principal editor
V.H. Curran, London
Advisory editor
M.A. Mehta, London
B.J. Sahakian, Cambridge
Molecular neuropsychopharmacology
For North and South America
Principal editor
D.R. Sibley, Bethesda
Advisory editors
C.C. Felder, Indianapolis
A.L. Morrow, Chapel Hill
M.M. Rasenick, Chicago
B.L. Roth, Chapel Hill
L.E. Schechter, Princeton
For the rest of the world
Principal editor
D. Hoyer, Basel
Advisory editors
J.F. Cryan, Cork
C.A. Marsden, Nottingham
Behavioral pharmacology in laboratory animals
For North and South America
Principal editor
K.A. Miczek, Medford
Advisory editors
C.L. Cunningham, Portland
K.A. Grant, Portland
F.S. Guimaraes, Ribeirao Preto
Y. Shaham, Baltimore
J. Taylor, New Haven
For the rest of the world
Principal editor
T.W. Robbins, Cambridge
Advisory editors
A. Badiani, Rome
M. Cador, Bordeaux
B. Ellenbroek, Hamburg
B.J. Everitt, Cambridge
I.P. Stolerman, London
L. Vanderschuren, Utrecht
Preclinical psychopharmacology
For North and South America
Principal editor
I. Lucki, Philadelphia
Advisory editors
C.W. Bradberry, Pittsburgh
J.N. Crawley, Bethesda
G.F. Koob, San Diego
N.R. Swerdlow, La Jolla
For the rest of the world
Principal editor
T. Steckler, Beerse
Advisory editors
M.I. Colado, Madrid
M.J. Millan, Paris
K. Fone, Nottingham
|
